International Biotechnology Trust’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-543,000
| Closed | -$10.5M | – | 69 |
|
|
2023
Q1 | $10.5M | Hold |
543,000
| – | – | 2.94% | 9 |
|
|
2022
Q4 | $8.71M | Hold |
543,000
| – | – | 2.69% | 13 |
|
|
2022
Q3 | $8.51M | Buy |
543,000
+535,710
| +7,349% | +$8.39M | 2.73% | 12 |
|
|
2022
Q2 | $350K | Buy |
+7,290
| New | +$350K | 3.65% | 8 |
|
|
2021
Q4 | – | Sell |
-489,534
| Closed | -$10.3M | – | 79 |
|
|
2021
Q3 | $10.3M | Buy |
489,534
+388,000
| +382% | +$8.2M | 2.49% | 13 |
|
|
2021
Q2 | $1.85M | Sell |
101,534
-785,000
| -89% | -$14.3M | 0.49% | 40 |
|
|
2021
Q1 | $20M | Buy |
886,534
+360,000
| +68% | +$8.13M | 5.3% | 5 |
|
|
2020
Q4 | $10.6M | Hold |
526,534
| – | – | 2.89% | 15 |
|
|
2020
Q3 | $12.9M | Buy |
526,534
+74,000
| +16% | +$1.81M | 4.15% | 8 |
|
|
2020
Q2 | $10.3M | Buy |
452,534
+349,000
| +337% | +$7.93M | 3.42% | 12 |
|
|
2020
Q1 | $1.78M | Hold |
103,534
| – | – | 0.81% | 23 |
|
|
2019
Q4 | $1.82M | Hold |
103,534
| – | – | 0.66% | 35 |
|
|
2019
Q3 | $1.83M | Sell |
103,534
-340,000
| -77% | -$6.01M | 0.85% | 28 |
|
|
2019
Q2 | $9.48M | Buy |
443,534
+200,000
| +82% | +$4.28M | 3.52% | 10 |
|
|
2019
Q1 | $5.79M | Sell |
243,534
-346,000
| -59% | -$8.23M | 2.14% | 17 |
|
|
2018
Q4 | $9.11M | Sell |
589,534
-115,000
| -16% | -$1.78M | 5.65% | 6 |
|
|
2018
Q3 | $9.57M | Buy |
704,534
+260,000
| +58% | +$3.53M | 4.55% | 7 |
|
|
2018
Q2 | $9.57M | Buy |
444,534
+56,200
| +14% | +$1.21M | 3.67% | 9 |
|
|
2018
Q1 | $8.6M | Sell |
388,334
-22,000
| -5% | -$487K | 3.35% | 11 |
|
|
2017
Q4 | $12.5M | Buy |
410,334
+156,000
| +61% | +$4.74M | 4.4% | 5 |
|
|
2017
Q3 | $6.16M | Buy |
254,334
+47,334
| +23% | +$1.15M | 2.4% | 13 |
|
|
2017
Q2 | $5.1M | Buy |
207,000
+76,000
| +58% | +$1.87M | 1.94% | 15 |
|
|
2017
Q1 | $2.84M | Sell |
131,000
-54,000
| -29% | -$1.17M | 1.09% | 25 |
|
|
2016
Q4 | $2.76M | Buy |
+185,000
| New | +$2.76M | 1.24% | 20 |
|